US: 7 sterility recalls on procedure kits, Sept 2026: what to check

US FDA enforcement reports list 7 sterility recall events covering 13 medical device procedure and convenience kit lines between September 16 and September 23, 2026, with 1 event classified as serious. The wave spans cataract, myringotomy, minor, anesthesia and open-heart packs, blood-culture, epidural and IV start kits, a Bayer MEDRAD contrast-injector syringe kit, and Maquet percutaneous insertion kits from five brands; 10 of 13 lines originate in the United States and 3 in Germany.

US medical device procedure-kit manufacturers and distributors, importers of German cardiopulmonary kits, Bayer MEDRAD syringe-kit distributors, and hospital sterile-processing and procurement departments holding the affected lots must immediately check stock and online listings against the 13 recalled kit references, quarantine affected lots, and review sterile-barrier packaging validation and supplier controls under 21 CFR Part 820, or the affected lots stay under active FDA recall with enforcement up to seizure, injunction and civil penalties under 21 CFR Part 803 and Part 820.

• Window : September 16 to September 23, 2026
• Alerts : 7 events, 13 product lines, 1 serious, posted by US FDA
• Risk : sterility, sterile-barrier breach (open pouch seals, compromised sterile-barrier integrity)
• Product family : medical device procedure and convenience kits (cataract, myringotomy, minor, anesthesia, open-heart, blood-culture, epidural, IV start, contrast-injector syringe, percutaneous insertion)
• Legal basis : FD&C Act medical-device provisions; 21 CFR Part 820 (Quality System Regulation) and 21 CFR Part 803 (Medical Device Reporting); no specific provision cited in the notices
• Official source : FDA Enforcement Report, event 99667 (Medline cataract, myringotomy, minor and anesthesia packs)

What was recalled

And 1 more product line in the same wave, listed in the Sources.

The pattern

The dominant defect is sterile-barrier failure. Four alerts state that kits may exhibit open seals in sterile pouch packaging, and three more state that the packaging may not consistently maintain sterile-barrier integrity, so 7 of 13 lines trace to a pouch or tray seal breach. The two Medical Action epidural kit lines under event 99613 are the serious alerts; one blood-culture kit and one epidural kit recall a component subject to a separate drug recall (Sodium Chloride ampules), and one kit contains BD ChloraPrep and FREPP applicators that lack sterility assurance. One Maquet percutaneous insertion kit flags a sterile-barrier breach in a Retrograde Coronary Sinus Perfusion cannula, and one line cites a manufacturing sterilization issue.

Medline Industries accounts for 5 of 13 lines, Medical Action Industries for 3 and Maquet Cardiopulmonary for 3; AVID Medical and Bayer Medical Care account for one each. Ten of 13 lines originate in the United States and three in Germany, all of them Maquet percutaneous insertion kits. Every measure is recall-ongoing. No source confirms a single shared supplier root cause, but the seal-integrity pattern spans five brands and both originating countries.

Who is exposed

By market exposure, the wave reaches US medical device procedure-kit and convenience-kit manufacturers and distributors (Medline Industries, Medical Action Industries, AVID Medical), US importers of German cardiopulmonary device kits (Maquet Cardiopulmonary, part of Getinge), US distributors of Bayer MEDRAD contrast-injector syringe kits, and US hospital sterile-processing and procurement departments holding the affected kit lots. US FDA is the regulator, not the exposed party.

What to check now

• Pull stock, online listings and distribution records against the 13 recalled kit references and lot codes, and quarantine any match.
• Verify sterile-barrier packaging validation and seal-integrity testing for pouch and tray seals under 21 CFR Part 820, and re-inspect retained samples.
• Review supplier controls and incoming inspection for kit components subject to separate drug recalls, including Sodium Chloride ampules and BD ChloraPrep and FREPP applicators.
• Check the device master record, device history record and conformity documentation for the affected convenience kits under the Quality System Regulation.
• Confirm Medical Device Reporting procedures under 21 CFR Part 803 are current for any serious injury or device deficiency linked to the affected lots.
• For Maquet percutaneous insertion kits imported from Germany, verify importer responsibilities, UDI assignment and distribution records.

Continuous, per-jurisdiction monitoring of FDA enforcement reports surfaces these waves as they publish.

Sources

• FDA Enforcement Report, event 99667: Medline cataract, myringotomy, minor and anesthesia packs
• FDA Enforcement Report, event 99628: Medical Action blood-culture venipuncture kit
• FDA Enforcement Report, event 99698: Bayer MEDRAD Stellant FLEX syringe kit
• FDA Enforcement Report, event 99668: Maquet percutaneous insertion kits
• FDA Enforcement Report, event 99583: Medline Open Heart A pack
• FDA Enforcement Report, event 99525: AVID Halyard IV start kit
• FDA Enforcement Report, event 99613: Medical Action epidural kits (serious)
• 21 CFR Part 820, Quality System Regulation (eCFR)
• 21 CFR Part 803, Medical Device Reporting (eCFR)